TUMORS OF THE PANCREAS AFIP ATLAS OF TUMOR AND NON-TUMOR PATHOLOGY - AFIP N° 15

The current multimodal study of pancreatic neoplasms has allowed a better understanding of tumor biology, more closely linking the mor¬phologic findings with clinical outcomes and targeted treatment.

The prognosis of conventional pancreatic ductal adenocarcinoma remains very poor, but some promise is on the horizon based on novel treatment approaches and the increase in earlier diagnosis.

Furthermore, intensive study of other pancreatic neoplasms has led to a clearer recognition that each type has distinctive biology and behavior that is often not so highly aggressive. This sense of optimism may help drive a resurgence of interest in pancreatic pathology.

Who are the authors of "Tumors of the Pancreas" ?

Dr. Klimstra is an internationally recognized leader in cancer pathology whose career spans more than three decades. Additionally, Dr. Klimstra has also authored more than 450 peer-reviewed publications related to his research on the pathology of pancreatic, hepatic, and gastrointestinal tumors. He has served as an editor of the World Health Organization’s standard classification series for tumors of the gastrointestinal tract and endocrine organs and he has authored four books and numerous book chapters. He is widely sought for his diagnostic expertise and has lectured extensively around the world.

David Klimstra served as the Chair of the Pathology Department and held the James Ewing Alumni Chair in Pathology from 2012-2021. 

Dr. Ralph Hruban is a professor of pathology and oncology at the Johns Hopkins University School of Medicine. A world-renowned pancreatic cancer pathology expert, his areas of clinical expertise include pancreatic cancer and its precursors, neuroendocrine tumors of the pancreas and pancreatic pathology.His research contributions include the characterization of PanINs, the precursor lesions that give rise to invasive pancreatic cancer.

Dr. Hruban is the Baxley Professor and Director of the Department of Pathology.  He also serves as director of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins and is a member of the Johns Hopkins Kimmel Cancer Center.